1型神经纤维瘤病合并乳腺癌1例报告及文献复习。

IF 1.2 Q4 ONCOLOGY Rare Tumors Pub Date : 2025-02-20 eCollection Date: 2025-01-01 DOI:10.1177/20363613251322866
Victor I Canice Nwagbara, John A Ashindoitiang, Theophilus Ipeh Ugbem, Dino N Magam, Chibuike M Meremikwu, Victor D Nnalue, Maurice E Asuquo
{"title":"1型神经纤维瘤病合并乳腺癌1例报告及文献复习。","authors":"Victor I Canice Nwagbara, John A Ashindoitiang, Theophilus Ipeh Ugbem, Dino N Magam, Chibuike M Meremikwu, Victor D Nnalue, Maurice E Asuquo","doi":"10.1177/20363613251322866","DOIUrl":null,"url":null,"abstract":"<p><p>Neurofibromatosis 1 (NF1) represents a cluster of clinical features based on the National Institute of Health(NIH) diagnostic criteria. It is a multi-systemic disease with progressive features characterized by variable expression. NF1 is associated with an increased risk of malignancies including breast cancer. Presented was a 56 year old woman with a painless lump in the right breast in the past 15 months. Clinical evaluation revealed features of NF1 and an advanced right breast cancer. Histologic evaluation revealed an invasive ductal carcinoma and she was offered a right modified radical mastectomy. Due to clinical presentation with discrete lesions, NF1 may be diagnosed at presentation with malignancy. Clinicians are urged to be familiar with the subtle features of NF1 for early diagnosis that is largely clinical. Institution of early breast cancer surveillance in patients with NF1 is recommended for early diagnosis and improved outcomes.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"17 ","pages":"20363613251322866"},"PeriodicalIF":1.2000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11843692/pdf/","citationCount":"0","resultStr":"{\"title\":\"Breast cancer in a patient with neurofibromatosis type 1: A case report and review of literature.\",\"authors\":\"Victor I Canice Nwagbara, John A Ashindoitiang, Theophilus Ipeh Ugbem, Dino N Magam, Chibuike M Meremikwu, Victor D Nnalue, Maurice E Asuquo\",\"doi\":\"10.1177/20363613251322866\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Neurofibromatosis 1 (NF1) represents a cluster of clinical features based on the National Institute of Health(NIH) diagnostic criteria. It is a multi-systemic disease with progressive features characterized by variable expression. NF1 is associated with an increased risk of malignancies including breast cancer. Presented was a 56 year old woman with a painless lump in the right breast in the past 15 months. Clinical evaluation revealed features of NF1 and an advanced right breast cancer. Histologic evaluation revealed an invasive ductal carcinoma and she was offered a right modified radical mastectomy. Due to clinical presentation with discrete lesions, NF1 may be diagnosed at presentation with malignancy. Clinicians are urged to be familiar with the subtle features of NF1 for early diagnosis that is largely clinical. Institution of early breast cancer surveillance in patients with NF1 is recommended for early diagnosis and improved outcomes.</p>\",\"PeriodicalId\":46078,\"journal\":{\"name\":\"Rare Tumors\",\"volume\":\"17 \",\"pages\":\"20363613251322866\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2025-02-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11843692/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rare Tumors\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/20363613251322866\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rare Tumors","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20363613251322866","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

神经纤维瘤病1 (NF1)代表了基于美国国立卫生研究院(NIH)诊断标准的一组临床特征。它是一种多系统的进行性疾病,以表达变化为特征。NF1与包括乳腺癌在内的恶性肿瘤风险增加有关。提出了一个56岁的妇女,在过去的15个月在右乳房无痛性肿块。临床评估显示NF1和晚期右乳腺癌的特征。组织学检查显示为浸润性导管癌,她接受了右侧改良乳房根治术。由于临床表现为离散病变,NF1可能在表现为恶性肿瘤时被诊断。临床医生被敦促熟悉NF1的细微特征,以便在很大程度上进行临床早期诊断。建议对NF1患者进行早期乳腺癌监测,以便早期诊断和改善预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Breast cancer in a patient with neurofibromatosis type 1: A case report and review of literature.

Neurofibromatosis 1 (NF1) represents a cluster of clinical features based on the National Institute of Health(NIH) diagnostic criteria. It is a multi-systemic disease with progressive features characterized by variable expression. NF1 is associated with an increased risk of malignancies including breast cancer. Presented was a 56 year old woman with a painless lump in the right breast in the past 15 months. Clinical evaluation revealed features of NF1 and an advanced right breast cancer. Histologic evaluation revealed an invasive ductal carcinoma and she was offered a right modified radical mastectomy. Due to clinical presentation with discrete lesions, NF1 may be diagnosed at presentation with malignancy. Clinicians are urged to be familiar with the subtle features of NF1 for early diagnosis that is largely clinical. Institution of early breast cancer surveillance in patients with NF1 is recommended for early diagnosis and improved outcomes.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Rare Tumors
Rare Tumors ONCOLOGY-
CiteScore
1.50
自引率
0.00%
发文量
15
审稿时长
15 weeks
期刊最新文献
Postoperative adjuvant eribulin in high-risk patients with soft tissue sarcoma: A retrospective study of eight cases. Palatal malignant peripheral nerve sheath tumor: A case report and review of literature. Durable remission of metastatic myxoid liposarcoma following the cautious addition of pembrolizumab to ongoing pazopanib treatment: A case report. Diagnostic utility of Ki-67 proliferation index, PSA, and other immunohistochemical markers in prostatic basal cell carcinoma: A review of 24 cases in the current literature and discussion on current treatment and diagnostics. Chronic myeloid leukemia presenting with isolated central nervous system lymphoid blast crisis: A case report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1